Patheon has opened its new early phase development facility in Milton Park in Oxfordshire, UK. The 13,500-sq.-ft development facility has newly constructed formulation labs and a fully equipped analytical lab. The facility will focus on the early phase development of solid, semi-solid and oral liquid dosage forms, and includes GMP manufacturing areas for the production of clinical trial materials for Phase I/II trials. The company’s Quick To Clinic programs, which work to accelerate molecu...